Net profit of pharmaceutical group “PROTEK” has grown to include representation stands at 10.97 billion. The company’s revenue grew by 24.4%, to $ 195,309 billion.
MOSCOW, 21 APR. Net profit of pharmaceutical group “PROTEK” in 2015, under IFRS has increased in 2,3 times in comparison with the previous year — up to representation stands at 10.97 billion rubles, according to the statements of the company.
The company’s revenue grew by 24.4%, to $ 195,309 billion.
The group of companies PROTEK has a diversified business structure and operates in all segments of the industry — production of medicines (“PharmFirma “Sotex”), distribution of pharmaceutical products and goods for beauty and health (“CV PROTEK), retail sales (pharmacy chain “Rigla”).
